| scholarly article | Q13442814 |
| P2093 | author name string | J Tang | |
| J Wu | |||
| L Huang | |||
| X Wang | |||
| X Zhang | |||
| W Huang | |||
| X Xu | |||
| Y Gu | |||
| T Chen | |||
| F Xu | |||
| H Zhou | |||
| G Xu | |||
| Y Fang | |||
| R Xu | |||
| S Zheng | |||
| Z Meng | |||
| Y Gan | |||
| J Jin | |||
| C Van Ness | |||
| X Gan | |||
| P2860 | cites work | Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients | Q43882758 |
| Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy | Q44327519 | ||
| beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia | Q46345796 | ||
| Initial sequencing and analysis of the human genome | Q21045365 | ||
| Reconstitution of an infectious human endogenous retrovirus | Q21559512 | ||
| LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation | Q24536102 | ||
| Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X | Q24562056 | ||
| Regulation of myeloid leukaemia by the cell-fate determinant Musashi | Q24634359 | ||
| Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements | Q24676640 | ||
| Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain | Q28749689 | ||
| Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma | Q29615115 | ||
| Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies | Q29615606 | ||
| Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein | Q33292072 | ||
| Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans | Q33872725 | ||
| Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution | Q34101407 | ||
| AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias | Q34212654 | ||
| Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells | Q34253011 | ||
| Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia | Q34541588 | ||
| Heterogeneous sensitivity of human acute myeloid leukemia to β-catenin down-modulation | Q34905557 | ||
| The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome | Q35077555 | ||
| Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. | Q35144582 | ||
| Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. | Q35164266 | ||
| Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors | Q35742389 | ||
| Human acute myeloid leukemias may be etiologically associated with new human retroviral infection | Q36808116 | ||
| Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer | Q36898870 | ||
| Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy. | Q37865381 | ||
| Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites. | Q39572030 | ||
| β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells | Q39620290 | ||
| Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein | Q40158980 | ||
| Expression of human endogenous retrovirus K in melanomas and melanoma cell lines | Q40421149 | ||
| HERV-K: the biologically most active human endogenous retrovirus family | Q41106251 | ||
| Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles | Q42030768 | ||
| Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W. | Q42673218 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 1469-1478 | |
| P577 | publication date | 2013-01-11 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells | |
| P478 | volume | 27 |
| Q30842942 | "Reverse genomics" and human endogenous retroviruses |
| Q90415585 | Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia |
| Q37269175 | Alterations of tumor microenvironment by carbon monoxide impedes lung cancer growth |
| Q89702908 | Characterising a human endogenous retrovirus(HERV)-derived tumour-associated antigen: enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines |
| Q36110284 | Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras |
| Q58796885 | Disruption by SaCas9 Endonuclease of HERV-K, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis |
| Q34120178 | Distinct isoform of FABP7 revealed by screening for retroelement-activated genes in diffuse large B-cell lymphoma. |
| Q28067477 | Endogenous retroviral promoter exaptation in human cancer |
| Q30234309 | Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs) |
| Q91671358 | Evaluating the expression level of HERV-K env, np9, rec and gag in breast tissue |
| Q37625774 | Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. |
| Q35123776 | Expression-analysis of the human endogenous retrovirus HERV-K in human astrocytic tumors. |
| Q52338720 | HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity. |
| Q37186225 | HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease |
| Q52682321 | HERVs New Role in Cancer: From Accused Perpetrators to Cheerful Protectors. |
| Q92017208 | HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA |
| Q55711521 | Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy. |
| Q90189900 | Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers |
| Q98612837 | Human Endogenous Retroviruses in Clear Cell Renal Cell Carcinoma: Biological Functions and Clinical Values |
| Q37539094 | Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. |
| Q27010373 | Human endogenous retrovirus K and cancer: Innocent bystander or tumorigenic accomplice? |
| Q34091109 | Human endogenous retrovirus np9 gene is over expressed in chronic lymphocytic leukemia patients |
| Q57466814 | Human endogenous retrovirus-K (HML-2): a comprehensive review |
| Q92356863 | Identification of leukemia stem cell expression signatures through Monte Carlo feature selection strategy and support vector machine |
| Q38529916 | Molecular functions of human endogenous retroviruses in health and disease. |
| Q36186500 | Np9, a cellular protein of retroviral ancestry restricted to human, chimpanzee and gorilla, binds and regulates ubiquitin ligase MDM2. |
| Q34059199 | Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein |
| Q97681546 | Reply to Comment on "UGT2B17 modifies drug response in chronic lymphocytic leukaemia" |
| Q35957393 | Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner. |
| Q64070092 | Structural variation of centromeric endogenous retroviruses in human populations and their impact on cutaneous T-cell lymphoma, Sézary syndrome, and HIV infection |
| Q41933413 | Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors |
| Q64091828 | The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells |
| Q53089292 | The landscape of somatic mutations in Down syndrome-related myeloid disorders. |
| Q54216669 | Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. |
| Q58803090 | Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins |
Search more.